Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPN | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
mRNA | MAST1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | LIG1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
mRNA | FEV | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-10 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | MSL2 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | WDTC1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |